Transcript Highlights:

• This is not a Medicaid expansion.
• Senator Kavanaugh, can you speak a little bit more about the rebates on pharmaceuticals?
• But you need your pharmaceutical partner to actually want to provide a rebate.
• When I met the advocates, the pharmaceutical folks.
• Browning, so you represent Otsuka, American Pharmaceutical.

Summary: The committee heard several bills related to radiation protection in cardiac catheterization labs and later a stem cell/regenerative therapy bill. On SB 1121, which would allow hospitals with radiation protection systems to let clinicians forgo lead aprons if they work in the designated safety area and use real-time dosimetry, testimony was largely supportive or neutral after a late amendment gave radiation safety officers discretion to require protective gear if exposures approach thresholds. The committee adopted the amendment and passed SB 1121 on a 9-1 vote. SB 1120, a more prescriptive bill requiring at least 50% of cath lab rooms in hospitals to be equipped with the radiation protection system, drew divided testimony: sponsors and several physicians argued it would reduce orthopedic injury and radiation exposure and improve recruitment and retention, while hospital and radiology groups objected to the mandate, cost, limited vendor pool, and lack of clarity in the bill’s definitions. After adopting an amendment excluding children’s hospitals, the committee deadlocked 6-6 and SB 1120 failed to pass. The committee then considered SB 1118, which would appropriate $3 million to help rural hospitals install radiation protection systems in cath lab rooms. The sponsor said the funding would help rural facilities meet the same safety goals, and the committee passed the bill 6-5. The committee also heard SB 1214, a “guardrails” bill regulating non-FDA-approved stem cell and regenerative therapies, requiring informed consent, sourcing and reporting standards, advertising limits, and civil penalties for violations. Supporters said it would protect patients while allowing access to promising therapies; some members raised concerns about evidence and commercialization, but after adopting a technical amendment, the bill passed 9-3. The transcript ended as the committee moved on to SB 1630, which would seek federal approval for a home- and community-based service benefit for adults with serious mental illness; the sponsor described it as a capped, Medicaid-based community care option, and Access testified neutral while estimating a fiscal impact, but no final action on SB 1630 appears in the excerpt.

Transcript Highlights:

• If every state would have been required to do Medicaid expansion, we've seen that in expansion states
• Um, you know, similar to that pharmaceuticals?
• It's more complicated to do pharmaceuticals than devices. >> Um, but I don't know.
• The only caveat is they don’t provide pharmaceuticals and if... ...provide pharmaceuticals, and that
• My ill-informed instinct is that we don't start with pharmaceuticals.

Keywords: 916, all

Transcript Highlights:

• Were they on pharmaceutical drugs? Were they on illicit or illegal drugs?
• If we find that illegal substances or pharmaceuticals are not, I don't know.
• If illegal substances or pharmaceuticals are not a major component, then we can settle that element of
• we have not been looking at the potential impact of illegal and illicit substances as well as pharmaceutical
• The expansion of the placement prohibition to daycare facilities means that most of these individuals

Summary: The Assembly Public Safety Committee heard several bills dealing with firearms, hit-and-run penalties, domestic violence, and sexually violent predator placement. AB 256 by Assemblymember DeMaio would add a one-year enhancement for certain firearm felonies involving controlled substances and require toxicology testing; supporters said it would provide transparency about the causes of gun violence, while opponents argued it duplicated existing law, was overbroad, and raised privacy concerns. AB 1281, also by DeMaio, would increase penalties for hit-and-run cases involving death or serious injury; supporters framed it as a response to a fatal case in the author’s district, while opponents said current law already provides strong penalties and the bill would remove judicial flexibility. Both bills drew no formal support beyond the author and were opposed by public defenders, civil liberties groups, and other advocates. AB 292 by Assemblymember Patterson, as amended, would increase punishment for repeat felony domestic violence offenders, including higher prison terms and a longer mandatory jail minimum for probationers with prior domestic violence convictions. The author and a survivor witness argued that early release can endanger victims and children, and the California State Sheriffs’ Association and California District Attorneys Association supported the measure. Opponents, including public defenders and advocacy groups, said existing law already escalates penalties, warned the bill could sweep too broadly or reduce flexibility, and urged more prevention-oriented responses. After discussion, the committee approved AB 292 as amended and sent it to Appropriations. AB 767 by Assemblymember Alanis would clarify that private and home-based schools, as well as daycare facilities, are covered by existing restrictions on conditional release placements for sexually violent predators. Supporters said the bill would better protect children and resolve inconsistent court interpretations, while opponents argued it could effectively bar placement in large parts of the state and undermine rehabilitation and due process. The committee passed AB 767 to Appropriations. The committee also approved the consent item AB 277. AB 1092, a vote-only reconsideration item from the prior year, was brought up without the author present and was defeated. Final reported outcomes were: AB 256 failed, AB 277 passed, AB 292 passed, AB 767 passed, AB 1281 failed, and AB 1092 failed.

Transcript Highlights:

• The construction of TDCJ expansion dorms is also included.
• Last session, I sponsored House Bill 4990, which created the Texas Pharmaceutical.
• our approach to managing medication costs. together and to be able to get the best prices on pharmaceutical
• House Bill 4638, relating to the Texas Pharmaceutical Initiative.
• House Bill 4638, relating to the Texas Pharmaceutical Initiative. Passage of House Bill 4638.

Bills: SB801, SB867, SB2717, SB2919, HJR7, HB4, HB14, HB27, HB42, HB46, HB100, HB111, HB112, HB121, HB126, HB146, HB186, HB223, HB229, HB322, HB367, HB500, HB521, HB640, HB705, HB783, HB1052, HB1056, HB1105, HB1106, HB1178, HB1211, HB1234, HB1306, HB1403, HB1449, HB1506, HB1661, HB1690, HB1871, HB1960, HB2017, HB2078, HB2128, HB2240, HB2243, HB2348, HB2407, HB2512, HB2820, HB2844, HB2853, HB2854, HB2885, HB3000, HB3005, HB3053, HB3057, HB3181, HB3333, HB3372, HB3425, HB3441, HB3516, HB3749, HB3783, HB3812, HB3848, HB3923, HB3963, HB4070, HB4134, HB4157, HB4158, HB4211, HB4449, HB4623, HB4638, HB4687, HB4690, HB4748, HB4749, HB4795, HB4848, HB5093, HB5115, HB5129, HB5138, HB5294, HB5616, HB5629, HB5646, HB5661, HB5672, HB5674, HB5699, HCR40, SJR5, SJR27, SJR59, SB4, SB6, SB8, SB9, SB10, SB12, SB22, SB23, SB25, SB27, SB34, SB36, SB37, SB38, SB40, SB57, SB140, SB261, SB293, SB441, SB447, SB467, SB512, SB650, SB777, SB785, SB924, SB1188, SB1281, SB1318, SB1333, SB1398, SB1448, SB1566, SB1579, SB1621, SB1723, SB1838, SB1862, SB2167, SB2405, SB2406, SB2407, SB2878, SB3059, SB3070, SB1, SB17, SB21, SB260, SB379, SB509, SB1198, SB1405, SB1506, SB1637, SB1833, SB2155, SB2308, SB2601, SB2778, HB300, HB2011, HB2525, HB5246, SJR36, SJR50, SJR63, SCR12, SCR39, SB2023, SB62, SB666, SB847, SB284, SB854, SB810, SB1505, SB583, SB507, SB1434, SB1772, SB2016, SB1122, SB731, SB397, SB508, SB1436, SB287, SB1882, SB393, SB1791, SB209, SB2429, SB1085, SB1975, SB2717, SB1262, SB636, SB2056, SB884, SB1200, SB1845, SB2458, SB801, SB3014, SB3013, SB758, SB2797, SB2076, SB2876, SB1640, SB1449, SB1181, SB1234, SB2926, SB2841, SB1528, SB1854, SB317, SB1250, SB2082, SB1237, SB2819, SB629, SB2608, SB1602, SB2009, SB867, SB640, SB1698, SB2680, SB913, SB1071, SB1086, SB1087, SB1483, SB1444, SB1553, SB1556, SB1703, SB2133, SB2297, SB2298, SB2622, SB2955, SB2334, SB1367, SB2044, SB2363, SB2565, SB1888, SB3036, SB3057, SB3043, SB3063, SB3035, SB203, SB2688, SB2522, SB2459, SB2655, SB2251, SB1884, SB2928, SB2566, SB2549, SB2553, SB2919, SB1944, SB1232, SB1798, SB2603, SB2607, SB2683, SB1319, SB3045, SB3071, HJR7, HB5115, HB3053, HB1403, HB223, HB748, HB5652, HB3395, HB180, HB1306, HB322, HB126, HB5650, HB4894, HB1629, HB5698, HB3171, HB2694, HB5664, HB4690, HB4464, HB3623, HB2520, HB2213, HB252, HB146, HB5596, HB3619, HB5320, HB5651, HB5670, HB5665, HB5437, HB5679, HB5699, HB5661, HB5662, HB5654, HB5672, HB5656, HB3812, HB3057, HB2035, HB721, HB346, HB2512, HB5695, HB5694, HB5674, HB3185, HB2348, HB1871, HB1135, HB101, HB5666, HB5677, HB5682, HB5658, HB4144, HB3642, HB3815, HB2686, HB2012, HB1960, HB227, HB654, HB1690, HB2128, HB4158, HB4630, HB1523, HB2078, HB1973, HB3333, HB3697, HB3546, HB3225, HB3181, HB2820, HB1506, HB1234, HB640, HB521, HB229, HB186, HB119, HB4795, HB4466, HB3749, HB1106, HB4, HB4170, HB3909, HB4081, HB4145, HB4157, HB4285, HB4463, HB4995, HB5138, HB5624, HB1449, HB2598, HB3629, HB4361, HB824, HB1868, HB4848, HB2243, HB40, HB117, HB3686, HB500, HB3793, HB112, HB104, HB1056, HB42, HB3000, HB100, HB2240, HB718, HB27, HB4904, HB4202, HB2853, HB5129, HB5093, HB4765, HB4748, HB4559, HB4350, HB4214, HB3388, HB3112, HB5196, HB4211, HB3516, HB3092, HB4233, HB4687, HB705, HB1094, HB2037, HB3005, HB3848, HB1105, HB121, HB3372, HB367, HB783, HB3336, HB3441, HB4449, HB5616, HB2407, HB2854, HB3425, HB5294, HB1178, HB4623, HB14, HB3963, HB1211, HB5646, HB5629, HB3783, HB4236, HB46, HB4638, HB1052, HB4070, HB5509, HB5435, HB4134, HB3923, HB3520, HB3320, HB2517, HB2488, HB5663, HB2731, HB3073, HB2655, HB2399, HB541, HB4099, HB111, HB1532, HB3483, HB2963, HB4580, HB3748, HB713, HB632, HB426, HB4730, HB127, HB5690, HB5689, HB5655, HB3385, HB2757, HB4359, HB5381, HB20, HB123, HB549, HB5606, HB2217, HB2594, HB796, HB150, HB1057, HCR141, HCR40, HCR59, HCR76, HCR81, HCR46, HCR111, HCR83, HCR84, HJR7, HB4, HB14, HB27, HB42, HB46, HB100, HB126, HB150, HB322, HB367, HB500, HB640, HB705, HB783, HB1105, HB1178, HB1211, HB1234, HB1506, HB1690, HB1871, HB2078, HB2128, HB2240, HB2243, HB2407, HB2512, HB2853, HB2854, HB3000, HB3057, HB3181, HB3372, HB3425, HB3441, HB3749, HB3783, HB3812, HB3923, HB3963, HB4070, HB4134, HB4157, HB4211, HB4449, HB4623, HB4638, HB4687, HB4748, HB4795, HB5093, HB5129, HB5616, HB5629, HB5699, HB229, HB521, HB1056, HB1106, HB5138, SR583, SCR52, HB223, HB229, HB521, HB1056, HB1106, HB1403, HB3053, HB5115, HB5138

Keywords: SB 801, birth certificate, birth record, certified copy, homeless, homelessness, unhoused, vital records, state registrar, local registrar, county clerk, fee waiver, identity documents, ID access, housing insecurity, shelter, transitional housing, Health and Safety Code, HHSC, Health and Human Services Commission

Transcript Highlights:

• And that's exactly why we concurrently advocated for the expansion of T-CUP.
• THC was a gateway to pharmaceutical medicines.
• We support the T-Cup expansion program, and we're grateful for that.
• This is about the pharmaceutical lobby. This is about the alcohol lobby.
• So it's just not keeping people off pharmaceuticals to use these products.

Bills: SB 5, SB 11, SB 12

Keywords: disaster relief, flood preparedness, emergency funding, local government support, meteorological forecasting, human trafficking, trafficking victim, compelling prostitution, affirmative defense, criminal defense, coercion, force fraud or coercion, sexual exploitation, victim protection, Penal Code, Texas criminal law, prosecution, party liability, affirmative defense statute, survivor rights

Summary: The Senate Committee on State Affairs took up Senate Bill 5, which Senator Perry described as a ban on intoxicating THC consumer products while preserving legal CBD, CBG, hemp seed, hemp seed protein powder, and hemp seed oil products. Perry argued that most retail THC products are already illegal under federal law, that the industry has used loopholes and misleading labeling to sell high-potency products, and that regulation would be ineffective because chemists can quickly alter formulations. He also said the bill would steer people with medical needs toward the Texas Compassionate Use Program (T-Cup), which he and other supporters described as the proper physician-guided alternative. Committee members and witnesses repeatedly discussed the distinction between legal hemp-derived products and intoxicating THC products, and Perry said the bill would not touch non-consumable hemp uses such as fiber and clothing. Invited testimony came from law enforcement and medical witnesses who supported the bill. Texas Police Chiefs Association representative Steve Dye, Kaufman County District Attorney Early Wiley, and Chambers County Sheriff Brian Hawthorne all said regulation would be too costly, too complex, and ultimately unenforceable, while a ban would be clearer and easier to enforce. They cited overloaded DPS labs, the need for expensive private testing, limited police and prosecutor resources, and the difficulty of keeping up with constantly changing cannabinoids and out-of-state products. Hawthorne and Wiley described raids and investigations involving warehouses, retail stores, cash seizures, and products they said were marketed to young people and often mislabeled or imported from other states. They also said the bill would help law enforcement by creating a clearer legal line and protecting legitimate CBD/CBG businesses. Dr. Lindy McGee, speaking for the Texas Medical Association and Texas Pediatric Society, testified that retail THC products pose serious risks to children and adolescents, including addiction, impaired brain development, psychosis, suicide attempts, self-harm, accidental toddler ingestions, and possible long-term cognitive effects. She said there is no effective medication treatment for THC addiction comparable to nicotine cessation tools, and she supported restrictions such as child-resistant packaging, no marketing to minors, and age limits, while opposing criminal penalties for possession by minors. Senators asked follow-up questions about brain development, memory, dementia risk, pregnancy, and cardiovascular effects. No vote was taken during the portion provided, and the committee continued with invited testimony and questions.

Transcript Highlights:

• Um, and when I was in Boston meeting with a group of people, I talked about biomedical and pharmaceutical
• "Well, we have 30,000 unfilled jobs in the realm of research and pharmaceutical and biomedical engineering
• jobs in the realm of<00:03:02.400><c> research</c><00:03:03.080><c> and</c><00:03:03.320><c> pharmaceutical
• </c><00:03:04.040><c> and</c> of research and pharmaceutical and of research and pharmaceutical and biomedical
• I look at what’s happening with LifeSci KY and Northern Kentucky University and our $85 million expansion

Keywords: Meeting Start 00:00:00 Roll Call 00:00:10 SB 6 Discussion 00:40 SB 6 Vote 00:13:30 Cochlear Implants 00:16:25, 958, all

Summary: The Senate Appropriations and Revenue Committee heard Senate Bill 6, sponsored by Senate President Robert Stivers, which would create an endowed research fund to support collaborative university research in Kentucky. Stivers described the bill as an extension of earlier higher-education research efforts, arguing that Kentucky should build research “hubs” by requiring or encouraging partnerships among universities and outside entities, with potential focus areas including health care, engineering, aerospace, agriculture, and other emerging fields. He said the proposal would establish five research tranches over five years and sought a $30 million endowment for each, generating annual interest to fund consortium-based research and leverage additional private and federal dollars. Senators Frommeyer, Neal, Givens, Boswell, and Richardson spoke in support, emphasizing economic development, job creation, and examples from other research clusters such as Boston and North Carolina’s Research Triangle. The committee voted 12-0 to report the bill favorably to the Senate floor. The committee then received a presentation from Dr. Matthew Bush of the University of Kentucky on pediatric hearing loss and cochlear implants. Bush explained that early hearing detection and intervention is critical because hearing loss in newborns is a neurocognitive emergency that affects language, literacy, and long-term outcomes. He outlined national screening benchmarks, Kentucky’s incidence of childhood hearing loss, and the high educational and societal costs of untreated hearing loss. Bush also highlighted disparities in rural and western Kentucky, where children face delayed diagnosis, longer waits for hearing aids or cochlear implants, and more difficulty accessing follow-up care. He described cochlear implants, the multidisciplinary care they require, and research showing improved language development, quality of life, and cost savings when children are treated early.

Transcript Highlights:

• We would also support expansion of this bill in any way to include more students.
• </c><00:10:55.959><c> of</c> and we would also support expansion of and we would also support expansion
• That's the most common type of pharmaceutical that we're talking about, and so those generally have,
• That's the most common type of pharmaceutical that we're talking about, and so those generally have,
• </c> most common uh type of pharmaceutical most common uh type of pharmaceutical that<00:38:43.920><c

Keywords: 912, senate, all

Transcript Highlights:

• What we lived through was an unprecedented expansion of government power, a test of how far officials
• The push to vaccinate ignores that pharmaceuticals historically only care about profits and cover up
• We do not want to have a mandate when pharmaceuticals can decide.
• I have a doctorate in polymer chemistry, and for part of my career, I worked in the pharmaceutical industry
• ..the people in Massachusetts are never again required to take an experimental liability-free pharmaceutical

Keywords: 995, all

Summary: The Joint Committee on Emergency Preparedness and Management held a hearing on several emergency management bills, with most of the testimony focused on Senate Bill 539, which would prohibit COVID-19 mRNA vaccination or gene-altering procedures as a condition of entry, employment, school attendance, or access to public venues. Senator Durant and many public witnesses supported the bill, arguing that COVID-era mandates were coercive, ineffective, and harmful, and that the state should not require proof of vaccination in future emergencies. One witness, Joanne Tuller, testified in opposition, saying the government should retain authority to impose public health measures in emergencies and warning against permanently limiting that power based on the COVID experience. The committee also heard testimony on Senate Bill 540, concerning the prevention of radioactive material discharge, with a Sierra Club representative and local residents opposing Holtec’s disposal of wastewater from the Pilgrim Nuclear Power Plant and citing health, environmental, and economic concerns in Plymouth and nearby communities. Senator Driscoll testified in support of Senate Bills 537 and 538, describing them as measures to strengthen the Commonwealth’s strategic preparedness stockpile and to create a framework for emergency response during surges in hospitalizations, including temporary waivers of prior authorization when hospitals are over capacity. In addition, Dr. Jennifer Carlson testified in support of H.885, a resolve creating a special commission on the field of emergency management, arguing that the profession should be more fully professionalized and staffed by dedicated experts rather than part-time “second hat” officials. Several other bills on the docket, including H.883 and H.84, had no sign-ups. The chair closed each bill’s testimony section as the list was exhausted, and the hearing was adjourned without any votes taken during the session.

Transcript Highlights:

• And those concerns have to do with two things, both with respect to expansive definitions.
• The first is that the way the courts have defined recklessly endangering has been extremely expansive
• And those concerns have to do with two things, both with respect to expansive definitions.
• The first is that the way the courts have defined recklessly endangering has been extremely expansive
• Lana and Bausch for generic drug price fixing, and she's filed a new lawsuit against another pharmaceutical

Keywords: 1182, all

Transcript Highlights:

• So you can see a significant increase in pharmaceutical expenditures.
• So there are expansions of benefits, expansions of populations, increased rates.
• We did also have some of the expansions.
• Another expansion that I'm sure you're aware of is the sort of expansion to comprehensive coverage for
• I will note on the rebates, I mean, excuse me, on the pharmaceutical spend, the net versus the gross,

Summary: The Assembly Budget Subcommittee on Health began with a hearing on the impacts of H.R. 1 on California health programs, focusing first on reproductive health state investments. HCAI outlined five state-funded reproductive health programs created after Dobbs, including uncompensated care, practical support, capital and clinical infrastructure, and workforce programs. Essential Access Health and Planned Parenthood testified that these funds have served hundreds of thousands of patients, but warned that the uncompensated care program is fully awarded and needs renewal, and that Title X and Medicaid-related federal uncertainty continues to threaten access. Members questioned who the uncompensated care program serves, why Medi-Cal covers a large share of abortions, and whether Planned Parenthood could expand prenatal services; public commenters urged continued support for reproductive health access. The committee then took up long-term care services and supports, starting with the HCBA and Assisted Living Waiver programs. DHCS reported large wait lists for both programs and said enrollment is limited by workforce and provider capacity, while LAO noted that increasing slots alone may not increase access without additional programmatic changes. Members pressed the department on whether more slots should be added given the lower cost of home- and community-based care compared with skilled nursing facilities, and public testimony argued that the wait lists should be reduced and that staffing concerns do not fully explain unused capacity. The committee also heard testimony on congregate living health facilities, where providers and a patient family described the homes as critical, lower-cost alternatives to nursing facilities for younger, medically complex people. Witnesses requested short-term bridge funding, while DHCS said it is proposing to transition CLFs into a managed care benefit by January 1, 2028, which would remove caps and expand access statewide. The final long-term care topic was PACE. DHCS explained that it has paused new PACE applications and service expansions for at least two years to reassess oversight capacity and develop a statewide strategic growth framework, while existing programs continue operating. CalPACE supported the pause as a planning measure but asked for four additional state nurse positions to reduce delays in level-of-care determinations and speed enrollment for frail older adults. Members shared personal stories about how PACE has helped family members and asked how the state will meet growing demand; DHCS said stakeholder engagement will begin later in the year and that some existing applications already in process will continue. Public commenters broadly supported PACE, HCBA, and CLF funding requests. The hearing then moved to the Department of Health Care Services’ 2026-27 Medi-Cal budget and related trailer bills. DHCS said Medi-Cal spending has grown due to coverage expansions, higher acuity, rising utilization, and especially pharmacy costs, and it described proposals to extend the current skilled nursing facility financing framework for one year while the state develops a new value-based payment strategy. LAO said most recent Medi-Cal spending growth has been driven more by higher per-enrollee costs than by caseload growth, with pharmacy spending growing especially quickly, and recommended better and more timely data to analyze the drivers. Members expressed concern about the rapid rise in Medi-Cal spending and asked for more detail on the largest cost increases.

Transcript Highlights:

• So you can see a significant increase in pharmaceutical expenditures.
• So there are expansions of benefits, expansions of populations, increased rates.
• We did also have some of the expansions.
• Another expansion that I'm sure you're aware of is the sort of expansion to comprehensive coverage for
• I will note on the rebates, I mean, excuse me, on the pharmaceutical spend, the net versus the gross,

Keywords: 988, house, all

Transcript Highlights:

• Has the expansion of gambling in those states caused any problems?

Bills: HB3834, HB3940, HB4346, HB2947, HB3257, HB3264, HB4326, HB4421, HB3944, HB3979, HB4118, SCR22, SB169, HB1047, HB2123, HB2650, HB3260, HB3403, SR41, HB3649, HB3742, HB3831, HB3996, HB4321, HB4339

Keywords: HB3834, Oklahoma Breakthrough Therapy Act, ibogaine, ibogaine-based therapeutics, ibogaine analogs, clinical trials, FDA approval, breakthrough therapy designation, opioid use disorder, substance use disorder, traumatic brain injury, mental health, neurological disorders, drug development, public-private partnership, State Department of Health, intellectual property, revolving fund, research funding, medical licensing

Transcript Highlights:

• Has the expansion of gambling in those states caused any problems?

Bills: HB3834, HB3940, HB4346, HB2947, HB3257, HB3264, HB4326, HB4421, HB3944, HB3979, HB4118, SCR22, SB169, HB1047, HB2123, HB2650, HB3260, HB3403, SR41, HB3649, HB3742, HB3831, HB3996, HB4321, HB4339

Keywords: HB3834, Oklahoma Breakthrough Therapy Act, ibogaine, ibogaine-based therapeutics, ibogaine analogs, clinical trials, FDA approval, breakthrough therapy designation, opioid use disorder, substance use disorder, traumatic brain injury, mental health, neurological disorders, drug development, public-private partnership, State Department of Health, intellectual property, revolving fund, research funding, medical licensing

Summary: The Senate convened with a quorum, heard an invocation, and recognized several guests and groups in the gallery, including the Ponca City High School Poe High Steppers, the Edmond Democratic Women, family members of senators, a Grace Reform Baptist Church co-op group, and Oklahoma 4-H participants. The chamber also honored the Red Oak Lady Eagles state championship basketball team with a citation and remarks celebrating their first school basketball title and strong season. The Senate adopted Senate Concurrent Resolution 22, supporting the Lights Out Oklahoma campaign to reduce bird mortality during migration by encouraging reduced exterior lighting in peak migration months. The chamber also adopted Senate Resolution 41, proclaiming April 22, 2026, as the 27th annual 4-H Day at the Capitol, with testimony from 4-H representatives emphasizing youth leadership, civic engagement, and workforce readiness. Several bills passed, including House Bill 169 (house amendments adopted and the bill passed as an emergency measure), House Bill 2123 on the Arkansas River bridge, House Bill 2650 on summary administration estate thresholds, House Bill 3260 on funeral director continuing education approvals, House Bill 3403 on a DEQ/OSU sewage sludge pilot study, House Bill 3649 on the Mental Health Department real property trust, House Bill 3742 on criminal discovery, House Bill 3831 on a Task Force One revolving fund, House Bill 3996 on indigent defense experts in capital cases, House Bill 4321 on limits on retroactive building rule application, and House Bill 4339 on summary administration notice timing. House Bill 1047, which would have authorized a tribal sports betting framework and related revenue distributions, drew extensive debate over gambling addiction, revenue, tribal compacts, geofencing, and NIL funding, but failed 21-27; Senator Coleman gave notice of intent to reconsider. The Senate then announced an Appropriations Committee meeting and adjourned until the next scheduled session.

Bills: HB4421, HB4426, HB4432, HB4329, HB3551, HB3763, HB1411, HB2730, HB3465, HB3649, HB3650, HB3674, HB3941, HB3970, HB3979, HB3980, HB3981, SB1074

Keywords: child welfare, fentanyl exposure, drug endangerment, environmental testing, safety analysis, remediation, child protection, Department of Human Services, violence prevention, HB4426, SIDE tax credit, strategic industrial development enhancement, income tax credit, economic development, tax incentive, qualified economic development expenditures, qualified initial infrastructure expenditures, industrial park, economic development zone, port authority

Bills: HB4421, HB4426, HB4432, HB4329, HB3551, HB3763, HB1411, HB2730, HB3465, HB3649, HB3650, HB3674, HB3941, HB3970, HB3979, HB3980, HB3981, SB1074

Keywords: child welfare, fentanyl exposure, drug endangerment, environmental testing, safety analysis, remediation, child protection, Department of Human Services, violence prevention, HB4426, SIDE tax credit, strategic industrial development enhancement, income tax credit, economic development, tax incentive, qualified economic development expenditures, qualified initial infrastructure expenditures, industrial park, economic development zone, port authority

Bills: HB4421, HB4426, HB4432, HB4329, HB3551, HB3763, HB1411, HB2730, HB3465, HB3649, HB3650, HB3674, HB3941, HB3970, HB3979, HB3980, HB3981, SB1074

Keywords: child welfare, fentanyl exposure, drug endangerment, environmental testing, safety analysis, remediation, child protection, Department of Human Services, violence prevention, HB4426, SIDE tax credit, strategic industrial development enhancement, income tax credit, economic development, tax incentive, qualified economic development expenditures, qualified initial infrastructure expenditures, industrial park, economic development zone, port authority

Summary: The committee heard a bill presented by the Speaker, who said the measure was prompted by a constituent request and was intended to protect children in Oklahoma from fentanyl-related harm. He noted he would file a floor amendment to rename it “Leo’s Law” in memory of a person lost to fentanyl. The chair also announced a work draft, PCS-1, which the Speaker agreed to adopt. Members asked about how the bill would work in practice. One question raised whether the bill could require a home to be inspected and cleaned of fentanyl residue before a child is returned; the Speaker said he liked the idea and was open to working it into a floor amendment with DHS. Another member asked whether the bill simply mirrored current child endangerment law or strengthened it, and the Speaker said it was intended to strengthen existing law in response to fentanyl’s severity. A follow-up question about age and circumstances prompted the Speaker to say the bill was meant to give judges, DHS, and district attorneys tools to protect children in a wide range of situations. After questions ended, the committee moved to a due pass motion. The bill passed the committee 31-0, and the chair reported it out with a due pass recommendation. The committee then stood at recess.

Transcript Highlights:

• Were they on pharmaceutical drugs? Were they on illicit or illegal drugs?
• If we find that illegal substances or pharmaceuticals are not, I don't know.
• That illegal substances or pharmaceuticals are not a major component, then we can settle that element
• we have not been looking at the potential impact of illegal and illicit substances as well as pharmaceutical
• The expansion of the placement prohibition to daycare facilities means that most of these individuals

Keywords: 988, house, all

Summary: The Assembly Committee on Public Safety heard six bills. AB 256 by Assembly Member DeMaio would add a one-year enhancement for felonies involving a firearm and a controlled substance and require toxicology testing; the author said it was meant to gather data on what may be fueling gun violence. Opponents, including public defenders and advocacy groups, argued it was duplicative, overbroad, and would create privacy and due process concerns. The chair and several members said existing law already covers the conduct and that the bill was not limited to mass shootings. The committee voted no on AB 256, and it failed. AB 1281, also by DeMaio, sought tougher penalties for hit-and-run cases involving death or serious injury, framed by the author as a response to a fatal case in his district. Support came from the California State Sheriffs’ Association, while opponents said the bill was unnecessarily punitive, inconsistent with existing vehicle homicide laws, and would remove judicial flexibility. The chair recommended no, citing sentencing inconsistencies and the availability of other charges; the bill failed. AB 292 by Assembly Member Patterson, as amended, would increase penalties for repeat felony domestic violence offenders, including higher prison terms and a longer mandatory jail term for probationers with prior domestic violence convictions. The author and a survivor witness argued the bill would better protect victims and children from repeat abusers. Opponents warned it could sweep too broadly and impose mandatory minimums that could affect survivors. After amendments and discussion, the committee passed AB 292. The committee also passed AB 277 on consent and AB 767 by Assembly Member Alanis, which clarifies that private and home-based schools and daycare facilities are covered under sexually violent predator placement restrictions; supporters said it would better protect children, while opponents argued it could create overly broad exclusion zones and undermine rehabilitation. Finally, AB 1092 by Assembly Member Castillo, a vote-only item from the prior year, was defeated. Final reported outcomes were: AB 256 failed, AB 277 passed, AB 292 passed, AB 767 passed, AB 1281 failed, and AB 1092 failed.

Transcript Highlights:

• the discussions that have been having around affordability, especially in the space of pharmacy pharmaceuticals
• the discussions that have been having around affordability, especially in the space of pharmacy pharmaceuticals
• of them for questions. been having around affordability, especially in the space of pharmacy pharmaceuticals
• >> Correct. >> So what would expansion entail?

Bills: SCR96, SCR109, SCR164, SCR172, SCR166

Keywords: electric reliability, renewable energy, interconnection, Hawaii Electric Reliability Administrator, Public Utilities Commission, capacity shortfalls, energy policies, mail-order pharmacy, insurance, healthcare access, chronic disease management, cost savings, rural access, emergency healthcare, patient adherence, critical infrastructure, foreign influence, local control, energy dependence, economic resilience

Summary: The Committee on Consumer Protection and Commerce heard several Senate concurrent resolutions related to utilities, pharmacy access, critical infrastructure, and energy policy. STR 96 SD1 asked the Public Utilities Commission (PUC) to report on the progress of the Hawaii Electric Reliability Administrator; the PUC offered written comments and the measure later advanced as is. STR 109 SD1 urged the insurance commissioner to study expanding mail-order pharmacy use. Testimony was split: DCCA’s insurance division, HMSA, and the Hawaii Association of Health Plans supported the study, while Shipa and the Hawaii Pharmacist Association opposed it, arguing mail-order pharmacy is already available and that in-person pharmacist counseling should be preserved. The measure was ultimately deferred. The committee also heard STR 164 SD1 on protecting Hawaii’s critical infrastructure from foreign influence. Greenpeace Hawaii and 350 Hawaii strongly supported the resolution, framing it as a consumer protection and resilience measure tied to reducing dependence on imports and strengthening local food and energy systems. No opposition was presented, and the resolution was moved out as is. STR 172 SD1 HD1 directed the PUC to conduct a comprehensive analysis of ways to maximize cost reduction and minimize financial risk while meeting state goals. DCCA, the Hawaii State Energy Office, and the PUC offered comments, and Earthjustice supported the measure; it was also advanced as is. For STR 166 SD1, which concerns how the PUC should evaluate generational energy commitments, DCCA, the Hawaii State Energy Office, and the PUC provided comments, while 350 Hawaii, Greenpeace Hawaii, and others opposed any move toward LNG, arguing it would harm ratepayers and conflict with Hawaii’s renewable goals. After discussion, the committee amended the resolution to add language directing the PUC to evaluate any LNG or other imported-fuel proposal for its potential effects on or delays to the state’s renewable portfolio standards, including the 2045 deadline. The amended resolution then passed, and the committee adjourned.

Transcript Highlights:

• But I sat there and thought about my prior life where we were contracting for pharmaceuticals within
• But the federal government cracked down years ago on how much a pharmaceutical rep could leave with a
• They contract the pharmaceutical manufacturers and have very large—” “Pharmaceutical manufacturers and
• “You cannot get that brand of pharmaceutical filled immediately because it’s going out of where they
• So I too favor scope expansion when it’s appropriate with the underlying tenant that we do no harm.

Summary: The House convened with Girl State participants presiding for part of the session, including introductions of the student leadership and a unanimous voice vote passing House Concurrent Resolution 152 honoring the young women participating in Delaware Girl State. The chamber also welcomed congressional interns and other guests, accepted the prior day’s minutes, and observed a moment of silence for Nathan Cynix and Kara Feeley before prayer and the Pledge of Allegiance. A major portion of the meeting was devoted to tributes for Representative Ron Gray, who was recognized for his 14 years of service and his work on issues such as bond bills, dredging, bike paths, small business, constituent service, and agriculture-related funding. Multiple members from both parties praised his humor, honesty, mentorship, and dedication to the House and his district. Gray responded with extended remarks reflecting on his family legacy, legislative service, and appreciation for colleagues and staff, and the chamber later sang “Take Me Out to the Ball Game” at his request. The House then received communications, including Senate messages returning several bills and informing the chamber of Senate passage of additional measures. Members were also told that the FY27 bond bill, House Bill 500, had been placed on desks as a gift for review. The House read in Consent Agenda S, which included House Bill 476, House Joint Resolution 13, Senate Substitute 1 for Senate Bill 168, Senate Bill 297, Senate Substitute 1 for Senate Bill 319, and Senate Joint Resolution 21, and began a roll call vote on the consent agenda.

Transcript Highlights:

• Our concern with this bill is the expansion of the buffer zones.
• Our concern with this bill is the expansion of the buffer zones.
• But it normally comes through a pharmaceutical company. It might be.
• So the pharmaceutical would then have to be a certified pesticide. Correct.
• </c> pharmaceutical company. pharmaceutical company.

Bills: SB2350, SB2349, SB2407, SB3320

Keywords: agriculture, aquaculture, livestock, agribusiness, Department of Agriculture, regulatory functions, employee benefits, restorative practices, sustainability, environmental stewardship, local food systems, Native Hawaiian, workforce development, agricultural development, Hawaii Island, property manager, state employment, SB3320, Hawaii, Agribusiness Development Corporation

Summary: The committee heard testimony on SP 2350, which would transfer oversight of the Department of Agriculture’s Agricultural Development Division and the aquaculture and livestock support services branch to the Agribusiness Development Corporation. The Department of Agriculture and ADC both testified, with ADC opposing the bill as written while supporting the goal of strengthening agriculture. ADC said the transfer could create federal operational and coordination risks, jeopardize federal funding and program continuity, and was unnecessary because ADC is a business development entity, not a regulatory agency. The Hawaii Farmers Union also expressed concern that moving the programs could weaken the department’s ability to access federal resources, while the Hawaii Farm Bureau submitted written testimony and the Hawaii Aquaculture and Aquaponics Association and H-Plan were noted as supporting the measure; the Hawaii Cattlemen’s Council was noted as opposing it. Much of the discussion focused on aquaculture’s economic potential and the role of regulation, permitting, and funding. Committee members questioned why aquaculture had not grown faster, citing current gross revenues of about $66 million last year, a prior high of $82 million, and a possible long-term target of $500 million. Testimony identified permitting and feed costs as major barriers, along with market conditions and water quality issues affecting producers. ADC described ongoing efforts on feed development, permitting streamlining, coastal-state collaboration on seaweed and restorative aquaculture, and national advocacy for more parity in seafood import standards. Members also pressed the Department of Agriculture on its leadership and priorities, criticizing the lack of bills and resources dedicated to aquaculture and asking whether the department should have more authority to pursue land purchases and development opportunities. The department said it relies on divisions and industry feedback for bill ideas, noted it funds an annual aquaculture survey, and said it was pursuing congressional earmarks and other funding for aquaculture parks, research, and export/import issues. ADC said it would work with the department if the bill passed, but that its current statute does not give it regulatory authority and any such change would require a statutory amendment.